RT Journal Article
SR Electronic
T1 Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch <em>et al</em>
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006617
DO 10.1136/jitc-2022-006617
VO 11
IS 3
A1 Chheda, Zinal S
A1 Mueller, Sabine
A1 Hegde, Bindu
A1 Yamamichi, Akane
A1 Butterfield, Lisa H
A1 Okada, Hideho
YR 2023
UL http://jitc.bmj.com/content/11/3/e006617.abstract